Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

Mental disorders account for at least 18% of global disease burden, and the associated
annual global costs are projected to be US $6 trillion by 2030. Evidence-based, cost …

The methods and results of systematic reviews should be reported in sufficient detail to allow
users to assess the trustworthiness and applicability of the review findings. The Preferred …

People living with severe mental illness (SMI) are one of the most marginalized groups in
society. Interventions which aim to improve their social and economic participation are of …

Importance Clinical trials have identified numerous prescriptive predictors of mental disorder
treatment response, ie, predictors of which treatments are best for which patients. However …

Background Relapse in psychiatric disorders is highly distressing that posed a huge burden
to the patients, family, and society. It interrupts the process of recovery and may increase the …

In many countries, including patients are legally entitled to request copies of their clinical
notes. However, this process remains time-consuming and burdensome, and it remains …

In psychiatry, the selection of antipsychotics and antidepressants is generally led by a trial-
and-error approach. The prescribing of these medications is complicated by sub-optimal …

Neuroscience, neurology, and psychiatry are rapidly evolving fields that aim to understand
the complex mechanisms underlying brain function and dysfunction, as well as to develop …

Major depressive disorder (MDD) is a mental health disorder that can cause disability and
functional impairment that standard-of-care (SOC) antidepressant therapies (ADTs) can take …